Latin American Cooperative Oncology Group

This study tests a combination of three drugs (datopotamab deruxtecan, carboplatin, and pembrolizumab) in people with non-small cell lung cancer that has spread to the brain and who have not had prior treatment for these brain tumors. The goal is to see if the treatment can shrin…